A diverse panel of hepatitis C virus glycoproteins for use in vaccine research reveals extremes of monoclonal antibody neutralization resistance
Despite significant advances in the treatment of hepatitis C virus (HCV) infection, the need to develop preventative vaccines remains. Identification of the best vaccine candidates and evaluation of their performance in preclinical and clinical development will require appropriate neutralization ass...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Society for Microbiology
2016
|
| Online Access: | http://eprints.nottingham.ac.uk/34388/ http://eprints.nottingham.ac.uk/34388/ http://eprints.nottingham.ac.uk/34388/ http://eprints.nottingham.ac.uk/34388/1/J.%20Virol.-2016-Urbanowicz-3288-301.pdf |